Cargando…

Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes

Multiple myeloma (MM) is a plasma-cell (PC) malignancy that is heterogeneous in its clinical presentation and prognosis. Monoclonal gammopathy of undetermined significance (MGUS) consistently preceded development of MM. The presence of primary IgH translocations and the universal overexpression of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Bougie, Patricia, Amiot, Martine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870331/
https://www.ncbi.nlm.nih.gov/pubmed/24391642
http://dx.doi.org/10.3389/fimmu.2013.00467
_version_ 1782296696009523200
author Gomez-Bougie, Patricia
Amiot, Martine
author_facet Gomez-Bougie, Patricia
Amiot, Martine
author_sort Gomez-Bougie, Patricia
collection PubMed
description Multiple myeloma (MM) is a plasma-cell (PC) malignancy that is heterogeneous in its clinical presentation and prognosis. Monoclonal gammopathy of undetermined significance (MGUS) consistently preceded development of MM. The presence of primary IgH translocations and the universal overexpression of cyclin D genes led to a molecular classification of MM patients into different disease subtypes. Since Bcl-2 family proteins determine cell fate, we analyzed a publicly available Affymetrix gene expression of 44 MGUS and 414 newly diagnosed MM patients to investigate (1) the global change of Bcl-2 family members in MM versus MGUS (2) whether the four major subtypes defined as hyperdiploid, CyclinD1, MAF, and MMSET, display specific apoptotic machineries. We showed that among the main anti-apoptotic members (Bcl-2, Bcl-x(L), and Mcl-1), Mcl-1 up-regulation discriminated MM from MGUS, in agreement with the prominent role of Mcl-1 in PC differentiation. Surprisingly, the expression of multi-domain pro-apoptotic Bak and Bax were increased during the progression of MGUS to MM. The combined profile of Bcl-2, Bcl-x(L), and Mcl-1 was sufficient to distinguish MM molecular groups. While specific pro-apoptotic members expression was observed for each MM subtypes, CyclinD1 subgroup, was identified as a particular entity characterized by a low expression of BH3-only (Puma, Bik, and Bad) and multi-domain pro-apoptotic members (Bax and Bak). Our analysis supports the notion that MM heterogeneity is extended to the differential expression of the Bcl-2 family content in each MM subgroup. The influence of Bcl-2 family profile in the survival of the different patient groups will be further discussed to establish the potential consequences for therapeutic interventions. Finally, the use of distinct pro-survival members in the different steps of immune responses to antigen raises also the question of whether the different Bcl-2 anti-apoptotic profile could reflect a different origin of MM cells.
format Online
Article
Text
id pubmed-3870331
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-38703312014-01-03 Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes Gomez-Bougie, Patricia Amiot, Martine Front Immunol Immunology Multiple myeloma (MM) is a plasma-cell (PC) malignancy that is heterogeneous in its clinical presentation and prognosis. Monoclonal gammopathy of undetermined significance (MGUS) consistently preceded development of MM. The presence of primary IgH translocations and the universal overexpression of cyclin D genes led to a molecular classification of MM patients into different disease subtypes. Since Bcl-2 family proteins determine cell fate, we analyzed a publicly available Affymetrix gene expression of 44 MGUS and 414 newly diagnosed MM patients to investigate (1) the global change of Bcl-2 family members in MM versus MGUS (2) whether the four major subtypes defined as hyperdiploid, CyclinD1, MAF, and MMSET, display specific apoptotic machineries. We showed that among the main anti-apoptotic members (Bcl-2, Bcl-x(L), and Mcl-1), Mcl-1 up-regulation discriminated MM from MGUS, in agreement with the prominent role of Mcl-1 in PC differentiation. Surprisingly, the expression of multi-domain pro-apoptotic Bak and Bax were increased during the progression of MGUS to MM. The combined profile of Bcl-2, Bcl-x(L), and Mcl-1 was sufficient to distinguish MM molecular groups. While specific pro-apoptotic members expression was observed for each MM subtypes, CyclinD1 subgroup, was identified as a particular entity characterized by a low expression of BH3-only (Puma, Bik, and Bad) and multi-domain pro-apoptotic members (Bax and Bak). Our analysis supports the notion that MM heterogeneity is extended to the differential expression of the Bcl-2 family content in each MM subgroup. The influence of Bcl-2 family profile in the survival of the different patient groups will be further discussed to establish the potential consequences for therapeutic interventions. Finally, the use of distinct pro-survival members in the different steps of immune responses to antigen raises also the question of whether the different Bcl-2 anti-apoptotic profile could reflect a different origin of MM cells. Frontiers Media S.A. 2013-12-23 /pmc/articles/PMC3870331/ /pubmed/24391642 http://dx.doi.org/10.3389/fimmu.2013.00467 Text en Copyright © 2013 Gomez-Bougie and Amiot. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Gomez-Bougie, Patricia
Amiot, Martine
Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
title Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
title_full Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
title_fullStr Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
title_full_unstemmed Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
title_short Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
title_sort apoptotic machinery diversity in multiple myeloma molecular subtypes
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870331/
https://www.ncbi.nlm.nih.gov/pubmed/24391642
http://dx.doi.org/10.3389/fimmu.2013.00467
work_keys_str_mv AT gomezbougiepatricia apoptoticmachinerydiversityinmultiplemyelomamolecularsubtypes
AT amiotmartine apoptoticmachinerydiversityinmultiplemyelomamolecularsubtypes